急性高山病防治研究进展

熊娟; 鹿辉; 王荣; 贾正平

doi:10.3969/j.issn.1006-0111.2017.02.001

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

急性高山病防治研究进展

熊娟, 鹿辉, 王荣, 贾正平

文章导航 > 药学实践与服务 > 2017 > 35(2): 97-101

熊娟, 鹿辉, 王荣, 贾正平. 急性高山病防治研究进展[J]. 药学实践与服务, 2017, 35(2): 97-101. doi: 10.3969/j.issn.1006-0111.2017.02.001

引用本文:

熊娟, 鹿辉, 王荣, 贾正平. 急性高山病防治研究进展[J]. 药学实践与服务, 2017, 35(2): 97-101. doi: 10.3969/j.issn.1006-0111.2017.02.001

XIONG Juan, LU Hui, WANG Rong, JIA Zhengping. Research progress on prevention and treatment of acute mountain sickness[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(2): 97-101. doi: 10.3969/j.issn.1006-0111.2017.02.001

Citation:

XIONG Juan, LU Hui, WANG Rong, JIA Zhengping. Research progress on prevention and treatment of acute mountain sickness[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(2): 97-101. doi: 10.3969/j.issn.1006-0111.2017.02.001

急性高山病防治研究进展

doi: 10.3969/j.issn.1006-0111.2017.02.001

兰州总医院全军环境损伤防治重点实验室, 甘肃兰州 730050

基金项目: 国家自然科学基金（81401552）

Research progress on prevention and treatment of acute mountain sickness

Key Laboratory of the Plateau of Environmental Damage Control, Lanzhou General Hospital, Lanzhou 730050, China

摘要: 高海拔未习服人群快速进入高海拔地区易患急性高山病（acute mountain sickness，AMS）。AMS是一种以头痛为主要症状并伴有肠胃不适、眩晕、疲劳和失眠等症状的自限性疾病。虽然对AMS已经开展了大量研究，但业内对其病理机制以及有效防治等方面的认识还非常有限。深入认识AMS的诊断方法、危险因素和病理生理机制，对提出针对AMS有效的防治措施十分重要。本文基于课题组的前期研究和相关文献，较为系统地综述AMS的临床诊断、危险因素、病理生理机制和防治措施。
- 急性高山病 /
- 高海拔 /
- 防治措施
Abstract: Acute mountain sickness (AMS) is a self-limiting medical condition characterized by headache, nausea, fatigue, dizziness, and insomnia. AMS usually occurs after rapid ascent to high altitudes in non-altitude acclimatized individuals. Extensive studies have been done on AMS, but knowledge on the mechanism, prevention and treatment are still limited. It will help the prevention and treatment of AMS with deep understanding of its risk factors and mechanisms. In this article, we systematically reviewed the diagnosis, risk factors, developing mechanisms, preventions and treatments of AMS.
- acute mountain sickness (AMS) /
- high altitude /
- prevention and treatment of AMS

[1]	Bartsch P,Swenson ER. Clinical practice:Acute high-altitude illnesses[J]. N Engl J Med,2013,368(24):2294-2302.
[2]	Gonggalanzi,Labasangzhu,Nafstad P,et al. Acute mountain sickness among tourists visiting the high-altitude city of Lhasa at 3658 m above sea level:a cross-sectional study[J]. Arch Public Health,2016,74(1):1-7.
[3]	Fruhauf A,Burtscher M,Pocecco E,et al. Subjective assessment of acute mountain sickness:investigating the relationship between the Lake Louise Self-Report,a visual analogue scale and psychological well-being scales[J]. Springerplus,2016,5(1):1646.
[4]	Wu J,Chen Y,Luo Y. Evaluation of the visual analog score (VAS) to assess acute mountain sickness (AMS) in a hypobaric chamber[J]. PLoS One,2014,9(11):e113376.
[5]	Fiore DC,Hall S,Shoja P. Altitude illness:risk factors,prevention,presentation,and treatment[J]. Am Fam Physician,2010,82(9):1103-1110.
[6]	Richalet JP,Larmignat P,Poitrine E,et al. Physiological risk factors for severe high-altitude illness:a prospective cohort study[J]. Am J Respir Crit Care Med,2012,185(2):192-198.
[7]	DiPasquale DM,Muza SR,Gunn AM,et al. Evidence for cerebral edema,cerebral perfusion,and intracranial pressure elevations in acute mountain sickness[J]. Brain Behav,2016,6(3):e00437.
[8]	Fischer R,Vollmar C,Thiere M,et al. No evidence of cerebral oedema in severe acute mountain sickness[J]. Cephalalgia,2004,24(1):66-71.
[9]	Bailey DM,Roukens R,Knauth M,et al. Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache[J]. J Cereb Blood Flow Metab,2006,26(1):99-111.
[10]	Dubowitz DJ,Dyer EA,Theilmann RJ,et al. Early brain swelling in acute hypoxia[J]. J Appl Physiol,2009,107(1):244-252.
[11]	Mairer K,Gobel M,Defrancesco M,et al. MRI evidence:acute mountain sickness is not associated with cerebral edema formation during simulated high altitude[J]. PLoS One,2012,7(11):e50334.
[12]	Wilson MH,Milledge J. Direct measurement of intracranial pressure at high altitude and correlation of ventricular size with acute mountain sickness:Brian Cummins' results from the 1985 Kishtwar expedition[J]. Neurosurgery,2008,63(5):970-974; discussion 974-975.
[13]	Hackett PH,Roach RC. High-altitude illness[J]. N Engl J Med,2001,345(2):107-114.
[14]	Van Osta A,Moraine JJ,Melot C,et al. Effects of high altitude exposure on cerebral hemodynamics in normal subjects[J]. Stroke,2005,36(3):557-560.
[15]	Julian CG,Subudhi AW,Hill RC,et al. Exploratory proteomic analysis of hypobaric hypoxia and acute mountain sickness in humans[J]. J Appl Physiol,2014,116(7):937-944.
[16]	Lopez JI,Holdridge A,Mendizabal JE. Altitude headache[J]. Curr Pain Headache Rep,2013,17(12):383.
[17]	Wilson MH,Davagnanam I,Holland G,et al. Cerebral venous system and anatomical predisposition to high-altitude headache[J]. Ann Neurol,2013,73(3):381-389.
[18]	Wilson MH,Imray CH,Hargens AR. The headache of high altitude and microgravity——similarities with clinical syndromes of cerebral venous hypertension[J]. High Alt Med Biol,2011,12(4):379-386.
[19]	Lu H,Wang R,Xiong J,et al. In search for better pharmacological prophylaxis for acute mountain sickness:looking in other directions[J]. Acta Physiol (Oxf),2015,214(1):51-62.
[20]	Schumacker PT. Lung cell hypoxia:role of mitochondrial reactive oxygen species signaling in triggering responses[J]. Proc Am Thorac Soc,2011,8(6):477-484.
[21]	Kayser B,Dumont L,Lysakowski C,et al. Reappraisal of acetazolamide for the prevention of acute mountain sickness:a systematic review and meta-analysis[J]. High Alt Med Biol,2012,13(2):82-92.
[22]	Luks AM,McIntosh SE,Grissom CK,et al. Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness:2014 update[J]. Wilderness Environ Med,2014,25(4 Suppl):S4-14.
[23]	Tang E,Chen Y,Luo Y. Dexamethasone for the prevention of acute mountain sickness:systematic review and meta-analysis[J]. Int J Cardiol,2014,173(2):133-138.
[24]	Pandit A,Karmacharya P,Pathak R,et al. Efficacy of NSAIDs for the prevention of acute mountain sickness:a systematic review and meta-analysis[J]. J Community Hosp Intern Med Perspect,2014,4(4).
[25]	Lipman GS,Kanaan NC. Ibuprofen for prevention of acute mountain sickness:is bigger really better[J]. Wilderness Environ Med,2013,24(2):177-178.
[26]	Sun L,Ding MJ,Cai TC,et al. Development and preliminary test of a new plateau hyperbaric chamber[J]. Am J Emerg Med,2015,33(10):1497-1500.
[27]	Shah NM,Hussain S,Cooke M,et al. Wilderness medicine at high altitude:recent developments in the field[J]. OAJSM,2015,6:319-328.
[28]	Grissom CK,Roach RC,Sarnquist FH,et al. Acetazolamide in the treatment of acute mountain sickness:Clinical efficacy and effect on gas exchange[J]. Ann Intern Med,1992,116(6):461-465.
[29]	Swenson ER. Pharmacology of acute mountain sickness:Old drugs and newer thinking[J]. J Appl Physiol,2016,120(2):204-215.

[1]	徐璐璐, 刘爱军. 丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2024, 42(12): 1-8. doi: 10.12206/j.issn.2097-2024.202312027
[2]	石晓萍, 吕迁洲, 李晓宇, 许青. 泊沙康唑对比伏立康唑经验治疗或诊断驱动治疗免疫功能低下患者侵袭性霉菌病的成本-效果分析 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202401050
[3]	陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾. 基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 479-486. doi: 10.12206/j.issn.2097-2024.202401073
[4]	徐飞, 陈瑾, 鲁育含, 李志勇. 肠道菌群参与糖尿病肾病的机制研究进展 . 药学实践与服务, 2024, 42(5): 181-184, 197. doi: 10.12206/j.issn.2097-2024.202312023
[5]	丁华敏, 郭羽晨, 秦春霞, 宋志兵, 孙莉莉. 消风止痒颗粒通过降低白三烯水平对小鼠特应性皮炎急性瘙痒的治疗作用研究 . 药学实践与服务, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031

点击查看大图

计量

文章访问数: 3884
HTML全文浏览量: 375
PDF下载量: 374
被引次数: 0

急性高山病防治研究进展

doi: 10.3969/j.issn.1006-0111.2017.02.001

兰州总医院全军环境损伤防治重点实验室, 甘肃兰州 730050

基金项目: 国家自然科学基金（81401552）

收稿日期: 2016-08-30
修回日期: 2016-11-07

关键词:

急性高山病 /

高海拔 /

防治措施

摘要: 高海拔未习服人群快速进入高海拔地区易患急性高山病（acute mountain sickness，AMS）。AMS是一种以头痛为主要症状并伴有肠胃不适、眩晕、疲劳和失眠等症状的自限性疾病。虽然对AMS已经开展了大量研究，但业内对其病理机制以及有效防治等方面的认识还非常有限。深入认识AMS的诊断方法、危险因素和病理生理机制，对提出针对AMS有效的防治措施十分重要。本文基于课题组的前期研究和相关文献，较为系统地综述AMS的临床诊断、危险因素、病理生理机制和防治措施。